Outcomes of SARS-CoV-2 omicron infection in residents of long-term care facilities in England (VIVALDI): a prospective, cohort study

Autor: Krutikov, Maria, Stirrup, Oliver, Nacer-Laidi, Hadjer, Azmi, Borscha, Fuller, Chris, Tut, Gokhan, Palmer, Tom, Shrotri, Madhumita, Irwin-Singer, Aidan, Baynton, Verity, Hayward, Andrew, Moss, Paul, Copas, Andrew, Shallcross, Laura, The COVID-19 Genomics UK (COG-UK) Consortium, Smith, Darren, Bashton, Matthew, McCann, Clare, Young, Greg, Nelson, Andrew, Crown, Matthew, Henderson, John, Hollis, Amy, Stanley, William, Yew, Wen Chyin

Publikováno v: The Lancet Healthy Longevity. 3:e347-e355

Background: The SARS-CoV-2 omicron variant (B.1.1.529) is highly transmissible, but disease severity appears to be reduced compared with previous variants such as alpha and delta. We investigated the risk of severe outcomes following infection in res

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22d137bad5af37f7a6a7e70ab68431d4
https://doi.org/10.1016/s2666-7568(22)00093-9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical Effectiveness of SARS-CoV-2 Booster Vaccine Against Omicron Infection in Residents and Staff of Long-term Care Facilities: A Prospective Cohort Study (VIVALDI).

Autor: Stirrup O; Institute for Global Health, University College London, London, United Kingdom., Shrotri M; UCL Institute of Health Informatics, London, United Kingdom., Adams NL; UCL Institute of Health Informatics, London, United Kingdom., Krutikov M; UCL Institute of Health Informatics, London, United Kingdom., Nacer-Laidi H; UCL Institute of Health Informatics, London, United Kingdom., Azmi B; UCL Institute of Health Informatics, London, United Kingdom., Palmer T; Institute for Global Health, University College London, London, United Kingdom., Fuller C; UCL Institute of Health Informatics, London, United Kingdom., Irwin-Singer A; Department of Health and Social Care, London, United Kingdom., Baynton V; Department of Health and Social Care, London, United Kingdom., Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Hayward A; UCL Institute of Epidemiology & Healthcare, London, United Kingdom.; Health Data Research UK, London, United Kingdom., Copas A; Institute for Global Health, University College London, London, United Kingdom., Shallcross L; UCL Institute of Health Informatics, London, United Kingdom.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2022 Dec 29; Vol. 10 (1), pp. ofac694. Date of Electronic Publication: 2022 Dec 29 (Print Publication: 2023).

Antibody and cellular immune responses following dual COVID-19 vaccination within infection-naive residents of long-term care facilities: an observational cohort study.

Autor: Tut G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Lancaster T; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Sylla P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Butler MS; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Kaur N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Spalkova E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bentley C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Amin U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Jadir A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Hulme S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Ayodele M; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Tut E; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Bruton R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Krutikov M; Institute of Health Informatics, University College London, London, UK., Giddings R; Institute of Health Informatics, University College London, London, UK., Shrotri M; Institute of Health Informatics, University College London, London, UK., Azmi B; Institute of Health Informatics, University College London, London, UK., Fuller C; Institute of Health Informatics, University College London, London, UK., Baynton V; Health Security Agency UK, London, UK., Irwin-Singer A; Health Security Agency UK, London, UK., Hayward A; Health Data Research UK, London, UK., Copas A; Institute for Global Health, University College London, London, UK., Shallcross L; Institute of Health Informatics, University College London, London, UK., Moss P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.

Publikováno v: The lancet. Healthy longevity [Lancet Healthy Longev] 2022 Jul; Vol. 3 (7), pp. e461-e469. Date of Electronic Publication: 2022 Jul 04.